Skip to main content

Advertisement

Table 1 Baseline characteristic of HIV-HBV/HCV study population at the date of stored plasma

From: Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

Characteristics N = 127
Gender, n(%)  
Female 45 (35.4%)
Age, years  
Median (range) 34 (22, 56)
Mode of HIV transmission, n (%)  
Homosexual contacts 17 (13.4%)
Heterosexual contacts 20 (15.7%)
IDU 87 (68.5%)
Other/unknown 3 (2.4%)
Viral load, log10 copies/mL  
Median (IQR) 3.8 (3.0, 4.3)
CD4 count, cells/mmc  
Median (range) 596 (208, 1303)
Hepatitis co-infection, n (%)  
HBV+/HCV- 9 (7.1%)
HCV+/HBV- 118 (92.9%)
Time from HIV seroconversion, years  
Median (range) 5 (0, 25)
Calendar year of sample  
Median (range) 1998 (1997, 2008)
Biomarkers  
CD8CD38 + DR+, % (n = 120)  
Median (IQR) 45.0 (25.5, 54.9)
IL-6, pg/ml (n = 279)  
Median (IQR) 1.1 (0.6, 2.1)
LPS, pg/ml (n = 212)  
Median (IQR) 126.2 (75.0, 211.6)
sCD14, mg/ml (n = 294)  
Median (IQR) 3.6 (2.0, 5.6)
TNF-alfa, pg/ml (n = 286)  
Median (IQR) 2.3 (1.7, 3.4)
ALT, IU/l (n = 360)  
Median (IQR) 40.0 (23.0, 63.0)